{"id":"https://genegraph.clinicalgenome.org/r/03ef8d50-701b-42e5-ae9c-4d442f61ccacv1.0","type":"EvidenceStrengthAssertion","dc:description":"*ALG10* was first reported in relation to autosomal recessive congenital disorder of glycosylation in 2018 (Courage et al., PMID: 33798445). One unique frameshift variant that has been reported in one proband in one publication is included in this curation. The proband also had a homozygous variant in *ALG10B*, which could not be ruled out as a contributing factor to the probandâ€™s phenotype. This gene-disease relationship is also supported by a yeast model (Burda et al, PMID: 9597543) showing that *ALG10* is required for the terminal glucosylation step of the lipid-linked core oligosaccharide. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date April 3, 2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/03ef8d50-701b-42e5-ae9c-4d442f61ccac","GCISnapshot":"https://genegraph.clinicalgenome.org/r/477a729b-ac93-4873-8c3e-ba95d1080381","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/477a729b-ac93-4873-8c3e-ba95d1080381_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-04-11T20:37:28.126Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/477a729b-ac93-4873-8c3e-ba95d1080381_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-04-03T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/477a729b-ac93-4873-8c3e-ba95d1080381_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/477a729b-ac93-4873-8c3e-ba95d1080381_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3479dae4-1efb-4694-bb9a-d8f2f21d561f","type":"EvidenceLine","dc:description":"Only able to show a glycosylation defect, not a growth defect.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01629cb4-ae2c-431e-a92f-775e6bbb0d11","type":"Finding","dc:description":"Alg10 mutations lead to underglycosylation of carboxypeptidase (fig 1a). Alg10 mutated (fig 2) and deleted (fig 3) strains accumulated Glc2Man9GlcNAc2, suggesting that Alg10 affects the glucosyltransferase activity required for the terminal glucosylation step of the lipid-linked core oligosaccharide. The deletion strain also showed affected glycosylation (fig 1b). Alg10 mutations do not lead to growth defect (data not shown).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9597543","rdfs:label":"Burda Yeast Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/477a729b-ac93-4873-8c3e-ba95d1080381_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b2f1eef-931d-4163-9b2f-d2170073fabf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ebf3bbb-fbf7-42f5-ab99-f86b88da6d44","type":"EvidenceLine","dc:description":"Reduced for NMD- and consanguinity.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ebf3bbb-fbf7-42f5-ab99-f86b88da6d44_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Hypoglycosylation of ICAM1 and LAMP1 as seen by Western blot in patient fibroblasts (fig 4). Yeast ALG10 deletion strains transfected with empty vector or the identified variant showed multiple bands of CPY corresponding to hypo-glycosylated forms of the protein (fig 4B).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1ebf3bbb-fbf7-42f5-ab99-f86b88da6d44_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33798445","allele":{"id":"https://genegraph.clinicalgenome.org/r/da95d4be-8d21-432c-987f-5419f1bff567","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032834.4(ALG10):c.1171_1172del (p.Lys391ValfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2618232863"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7b2f1eef-931d-4163-9b2f-d2170073fabf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33798445","rdfs:label":"PME50","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/da95d4be-8d21-432c-987f-5419f1bff567"},"detectionMethod":"Trio WES","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"rare tonic clonic seizure","phenotypes":["obo:HP_0002650","obo:HP_0100543","obo:HP_0001251","obo:HP_0001513","obo:HP_0001336"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1ebf3bbb-fbf7-42f5-ab99-f86b88da6d44_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Limited","sequence":10237,"specifiedBy":"GeneValidityCriteria11","strengthScore":2.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/O9O2iWxDWdM","type":"GeneValidityProposition","disease":"obo:MONDO_0015286","gene":"hgnc:23162","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_477a729b-ac93-4873-8c3e-ba95d1080381-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}